EFFECTS OF METHYLPREDNISOLONE ON NUCLEUS PULPOSUS-INDUCED NERVE ROOT INJURY

被引:121
作者
OLMARKER, K
BYROD, G
CORNEFJORD, M
NORDBORG, C
RYDEVIK, B
机构
[1] Departments of Pathology, University of Gothenburg, Sahlgren Hospital, Gothenburg
[2] Department of Orthopaedics Sahlgren Hospital, Gothenburg University, Gothenburg
关键词
LOW BACK PAIN; SCIATICA; NERVE ROOTS; CAUDA EQUINA; METHYLPREDNISOLONE;
D O I
10.1097/00007632-199408150-00003
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Study Design. The effects of intervention by intravenous injection of methylprednisolone to reduce the nerve root injury after epidural application of autologous nucleus pulposus was studied in an experimental model on the pig cauda equina in 20 animals. Methods. Nucleus pulposus was harvested from a lumbar disc. After lowering the pH of the nucleus pulposus to 3.5 it was placed onto the sacrococcygeal cauda equina. Fifteen of the pigs received a single intravenous injection of 30 mg/kg methylprednisolone, 5 minutes, 24 hours, or 48 hours, respectively, after the application. After 7 days, the nerve conduction velocity was determined, and biopsies of the cauda equina was examined by lightmicroscopy. Results. In the five pigs that did not receive any methylprednisolone treatment, nerve conduction velocity was reduced, whereas it was normal in the pigs treated 5 minutes and 24 hours after nucleus pulposus application. In pigs treated after 48 hours, nerve conduction velocity was reduced only slightly. At the light microscopic level, significant changes occurred in all series. Conclusions. This study indicates that the nucleus pulposus-induced effects on nerve function in an experimental pig model may be reduced dramatically by high-dose methylprednisolone administration within 24-48 hours after epidural application.of autologous nucleus pulposus. The light microscopic changes were probably not significant for the nerve function. Instead, a morphologic explanation on a subcellular level should probably be sought.
引用
收藏
页码:1803 / 1808
页数:6
相关论文
共 27 条
  • [1] Anderson D.K., Means E.D., Waters T.R., Green E.S., Microvascular perfusion and metabolism in injured spinal cord after methylprednisolone treatment, J Neurosurg, 56, pp. 106-113, (1982)
  • [2] Anderson D.K., Demediuk P., Saunders R.D., Dugan L.L., Means E.D., Horrocks L.A., Spinal cord injury and protection, Ann Emerg Med, 14, pp. 816-821, (1985)
  • [3] Bracken M.B., Shepard M.J., Collins W.F., Et al., A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury, N Engl J Med, 322, 20, pp. 1405-1411, (1990)
  • [4] Braughler J.M., Hall E.D., Correlation of methylprednisolone levels in cat spinal cord with its effects on (NaK)- ATPase, lipidperoxidation, and alpha motor neuron function, J Neurosurg, 56, pp. 838-844, (1982)
  • [5] Diamant B., Karlsson J., Nachemson A., Correlation between lactate levels and pH in discs of patients with lumbar rhizopathies, Experientia, 24, pp. 1195-1196, (1968)
  • [6] Demopoulos H.B., Flamm E.S., Seligman M.L., Petronigro D.D., Tomasula J., Decrescito V., Further studies on free-radical pathology in the major central nervous system disorders: Effect on very high doses of methylprednisolone on the functional outcome, morphology, and chemistry of experimental spinal cord impact injury, Can J Physiol Pharmacol, 60, pp. 1415-1423, (1982)
  • [7] Hall E.D., Wolf D.L., A pharmacological analysis of the pathophysiological mechanisms of posttraumatic spinal cord ischemia, J Neurosurg, 64, pp. 951-961, (1986)
  • [8] Hall E.D., The neuroprotective pharmacology of methyl-prednisolone, J Neurosurg, 76, pp. 13-22, (1992)
  • [9] Holmes J.M., Sworn B.R., Lumbosacral root pain, Br Med J, 1, (1946)
  • [10] Jaffray D., Resorption O.B., A source of mechanical and inflammatory back pain?, Spine, 11, pp. 397-401, (1986)